BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17101925)

  • 1. Premorbid antiplatelet use and ischemic stroke outcomes.
    Li HF; Pan XD
    Neurology; 2006 Nov; 67(9):1723; author reply 1723. PubMed ID: 17101925
    [No Abstract]   [Full Text] [Related]  

  • 2. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
    Park MK; Smith PC; Wanserski G; Neher JO
    Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
    [No Abstract]   [Full Text] [Related]  

  • 3. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
    Bertelli M; Luongo R; Barcella L; Cavalli P
    Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premorbid antiplatelet use and ischemic stroke outcomes.
    Sanossian N; Saver JL; Rajajee V; Selco SL; Kim D; Razinia T; Ovbiagele B
    Neurology; 2006 Feb; 66(3):319-23. PubMed ID: 16382033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of antiplatelet drugs in ischaemic stroke prevention--update on new trials.
    Rother J
    Cerebrovasc Dis; 2007; 24 Suppl 1():112-5. PubMed ID: 17971646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
    Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; CantĂș C; Leyva A; Murillo L; Villarreal J; Vargas RD; AlegrĂ­a MA; Merino JG; Romano J;
    Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antiplatelet agents for prevention of ischemic stroke.
    Callison RC; Adams HP
    Neurol Clin; 2008 Nov; 26(4):1047-77, ix. PubMed ID: 19026902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate, degree, and predictors of recovery from disability following ischemic stroke.
    Hankey GJ; Spiesser J; Hakimi Z; Bego G; Carita P; Gabriel S
    Neurology; 2007 May; 68(19):1583-7. PubMed ID: 17485645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why test antiplatelet therapy in acute ischaemic stroke and how can this be done?
    Lindley RI; Sandercock PA
    Postgrad Med J; 1992; 68 Suppl 2():S14-8; discussion S18-9. PubMed ID: 1461865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 17. Discharge medications among ischemic stroke survivors.
    Sweileh WM; Sawalha AF; Zyoud SH; Al-Jabi SW; Abaas MA
    J Stroke Cerebrovasc Dis; 2009; 18(2):97-102. PubMed ID: 19251184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior antiplatelet use and infarct volume in ischemic stroke.
    Ovbiagele B; Buck BH; Liebeskind DS; Starkman S; Bang OY; Ali LK; Villablanca JP; Salamon N; Yun SW; Pineda S; Saver JL
    J Neurol Sci; 2008 Jan; 264(1-2):140-4. PubMed ID: 17854835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commencing antiplatelet therapy in older people after an acute ischaemic stroke.
    Fletcher EH; Newton JL; Gray CS
    Age Ageing; 2009 Mar; 38(2):142-4. PubMed ID: 19147738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.